{"hands_on_practices": [{"introduction": "Accurate tumor staging is the cornerstone of modern cancer care, directly influencing treatment decisions and prognosis. However, real-world cases often present complexities, such as multifocal disease, that challenge a straightforward application of staging rules. This exercise [@problem_id:4676404] hones your ability to apply the specific, and sometimes non-intuitive, conventions of the Tumor-Node-Metastasis (TNM) system for multifocal tumors. Mastering this rule is essential for correctly interpreting pathology reports and avoiding common errors like summing foci, which can lead to inaccurate staging and inappropriate patient management.", "problem": "A surgeon receives a definitive pathology report on a breast lumpectomy specimen showing a multifocal invasive carcinoma with two invasive foci, each separated by benign breast parenchyma. The greatest dimensions of the two invasive foci are $1.2$ cm and $0.8$ cm, respectively. There is no clinical or pathological evidence of involvement of the skin or chest wall, and ductal carcinoma in situ is present only as an adjacent component without extensive spanning.\n\nStarting from foundational, widely accepted staging principles for solid tumors, the Tumor–Node–Metastasis (TNM) system defines the primary tumor ($T$) category for breast carcinoma by the greatest dimension of invasive carcinoma in the breast and by specific anatomic criteria (skin or chest wall involvement), with the following well-tested facts:\n- The $T$ category reflects the greatest dimension of the invasive component of the primary carcinoma.\n- For multiple ipsilateral invasive foci separated by benign tissue (multifocal disease), the size for $T$ is determined by the largest invasive focus; the sizes of separate foci are not summed, and the average is not used.\n- For breast carcinoma, threshold cutoffs for size-based $T$ subcategories include T1 when the greatest invasive dimension is $\\le 2.0$ cm, with subcategories T1a ($>0.1$ cm and $\\le 0.5$ cm), T1b ($>0.5$ cm and $\\le 1.0$ cm), and T1c ($>1.0$ cm and $\\le 2.0$ cm). T2 is $>2.0$ cm and $\\le 5.0$ cm, and T3 is $>5.0$ cm. T4 denotes direct extension to the chest wall or skin, regardless of size.\n\nWhich option best states the correct measurement convention for multifocal invasive breast carcinoma in this setting and the resulting $T$ category for the case described?\n\nA. Sum the diameters of all invasive foci to determine the primary tumor size; with $1.2$ cm and $0.8$ cm, the combined size is $2.0$ cm, yielding T2.\n\nB. Use the greatest dimension of the largest invasive focus to determine tumor size; with a largest focus of $1.2$ cm, this yields T1c.\n\nC. Use the average of the diameters of the invasive foci; with an average of $1.0$ cm, this yields T1b.\n\nD. Use the total span of the region containing all foci as seen on imaging or gross examination; if the span is $2.5$ cm, this yields T2.\n\nE. Use the largest focus, but add the second focus if both are in the same quadrant; with $1.2$ cm and $0.8$ cm in one quadrant, this yields T1c.", "solution": "The problem statement was validated.\n**Givens:**\n*   A breast lumpectomy specimen with multifocal invasive carcinoma.\n*   Two invasive foci are present, separated by benign breast parenchyma.\n*   The greatest dimension of the first invasive focus is $1.2$ cm.\n*   The greatest dimension of the second invasive focus is $0.8$ cm.\n*   There is no evidence of skin or chest wall involvement.\n*   Ductal carcinoma in situ (DCIS) is adjacent and not extensive.\n*   The TNM system rule for multifocal disease is provided: \"the size for $T$ is determined by the largest invasive focus; the sizes of separate foci are not summed, and the average is not used.\"\n*   $T$ category size thresholds are provided: T1 $\\le 2.0$ cm (with subcategories T1a, T1b, T1c); T1c is defined as $>1.0$ cm and $\\le 2.0$ cm. T2 is defined as $>2.0$ cm and $\\le 5.0$ cm. T4 is defined by skin or chest wall extension.\n\n**Validation:**\n1.  **Scientific Grounding:** The problem is scientifically grounded. It presents a common clinical scenario in surgical oncology and uses the correct, internationally accepted principles of the AJCC (American Joint Committee on Cancer) TNM staging system for breast cancer. The rules provided for multifocal disease are accurate.\n2.  **Well-Posed:** The problem is well-posed. It provides all necessary data (foci sizes) and the explicit rules required for their interpretation, leading to a unique and unambiguous solution.\n3.  **Objective:** The problem is objective, using precise medical and numerical terminology without any subjective or ambiguous language.\n\n**Conclusion:** The problem statement is valid as it is factually correct, logically consistent, and well-posed. The problem tests the direct application of a clearly stated oncologic staging principle.\n\n**Derivation of Solution:**\nThe problem asks for the correct measurement convention and the resulting $T$ category based on the provided a priori principles.\n1.  The primary governing principle is explicitly stated: \"For multiple ipsilateral invasive foci separated by benign tissue (multifocal disease), the size for $T$ is determined by the largest invasive focus\".\n2.  The given measurements for the two invasive foci are $1.2$ cm and $0.8$ cm.\n3.  Following the stated principle, we must select the largest of these dimensions. The largest dimension is $1.2$ cm. This is the size that will be used for T-staging.\n4.  The problem provides the definitions for the $T$ subcategories. We must classify the size $1.2$ cm according to these definitions.\n    *   T1a: $>0.1$ cm and $\\le 0.5$ cm. ($1.2$ cm is not in this range).\n    *   T1b: $>0.5$ cm and $\\le 1.0$ cm. ($1.2$ cm is not in this range).\n    *   T1c: $>1.0$ cm and $\\le 2.0$ cm. ($1.2$ cm is in this range, as $1.0 < 1.2 \\le 2.0$).\n5.  The problem also states there is no skin or chest wall involvement, which correctly rules out a T4 designation.\n6.  Therefore, the correct convention is to use the largest focus size ($1.2$ cm), and the resulting pathologic $T$ category is T1c.\n\n**Evaluation of Options:**\n\n**A. Sum the diameters of all invasive foci to determine the primary tumor size; with $1.2$ cm and $0.8$ cm, the combined size is $2.0$ cm, yielding T2.**\nThe convention of summing the diameters is explicitly forbidden by the rules stated in the problem: \"...the sizes of separate foci are not summed...\". Furthermore, a size of exactly $2.0$ cm falls into the T1c category ($>1.0$ cm and $\\le 2.0$ cm), not the T2 category ($>2.0$ cm). The proposed convention is incorrect, and the resulting T-stage based on that flawed convention is also incorrect.\n**Verdict: Incorrect**\n\n**B. Use the greatest dimension of the largest invasive focus to determine tumor size; with a largest focus of $1.2$ cm, this yields T1c.**\nThis option correctly states the measurement convention as provided in the problem statement (\"use the greatest dimension of the largest invasive focus\"). It correctly identifies the largest focus size as $1.2$ cm. It then correctly applies the staging criteria, classifying a $1.2$ cm tumor as T1c because $1.0 \\text{ cm} < 1.2 \\text{ cm} \\le 2.0 \\text{ cm}$. Every part of this statement is correct.\n**Verdict: Correct**\n\n**C. Use the average of the diameters of the invasive foci; with an average of $1.0$ cm, this yields T1b.**\nThe convention of using the average is explicitly forbidden by the rules stated in the problem: \"...and the average is not used.\" While the calculation of the average ($(1.2+0.8)/2 = 1.0$ cm) and the corresponding stage (T1b) are arithmetically consistent, the underlying principle is wrong.\n**Verdict: Incorrect**\n\n**D. Use the total span of the region containing all foci as seen on imaging or gross examination; if the span is $2.5$ cm, this yields T2.**\nThis option proposes a measurement convention (total span) that is not the standard for pathologic T-staging of multifocal disease, which relies on the size of the largest invasive focus. It also introduces a hypothetical value ($2.5$ cm) that is not based on the provided pathologic findings. While such a measurement might be relevant for radiation oncology or surgical planning, it does not determine the pathologic $T$ stage.\n**Verdict: Incorrect**\n\n**E. Use the largest focus, but add the second focus if both are in the same quadrant; with $1.2$ cm and $0.8$ cm in one quadrant, this yields T1c.**\nThis option presents a fabricated, conditional rule (\"...add the second focus if both are in the same quadrant...\"). The TNM staging system does not have this rule; the size of the largest focus is used regardless of quadrant location. Although the final stage listed (T1c) happens to be correct, it is derived from an incorrect premise about the measurement convention. The question requires the correct convention *and* the resulting stage.\n**Verdict: Incorrect**", "answer": "$$\\boxed{B}$$", "id": "4676404"}, {"introduction": "Beyond the anatomic extent of a tumor, its intrinsic biological aggressiveness is a critical prognostic factor, captured by the histologic grade. The Nottingham grading system for breast cancer provides a structured method to assess tumor differentiation and proliferative activity. By working through this problem [@problem_id:4676442], you will deconstruct histologic grade into its core components—tubule formation, nuclear pleomorphism, and mitotic activity—reinforcing the biological principles that translate microscopic features into a meaningful prognosis.", "problem": "A surgeon reviews a pathology report for an invasive breast carcinoma resection in which the histologic grade must be determined to guide prognosis discussion and adjuvant therapy planning. The laboratory uses the Nottingham modification of the Bloom–Richardson system, which assigns an ordinal score to each of three histomorphologic components reflecting tumor differentiation and proliferative activity. Explain, drawing on core definitions of differentiation and proliferation in surgical pathology, what each component—tubule formation, nuclear pleomorphism, and mitotic count—intends to measure and why its ordinal increment reflects increasingly unfavorable biology. Then, using the established consensus approach in this system for converting the three component scores into a final histologic grade, determine the overall grade when the component scores are: tubule formation $2$, nuclear pleomorphism $3$, and mitotic count $1$. Report only the final numerical grade as an integer with no units.", "solution": "The problem statement is evaluated as valid. It is scientifically grounded in the established principles of surgical pathology, specifically the Nottingham grading system for invasive breast carcinoma. The problem is well-posed, providing all necessary information for a unique solution, and is expressed in objective, unambiguous language.\n\nThe Nottingham modification of the Bloom–Richardson grading system is a prognostic tool used for invasive breast cancer. It assesses the tumor's degree of differentiation and proliferative rate by evaluating three morphological features. The total score, derived from these components, correlates with patient prognosis, with higher grades indicating a worse outcome. The explanation for each component and the calculation of the final grade are as follows.\n\nFirst, we must define the core biological concepts underlying the grading system: differentiation and proliferation.\n**Differentiation** refers to the extent to which neoplastic cells resemble their corresponding normal, mature cells of origin, both in terms of individual cell morphology (cytologic differentiation) and their three-dimensional organization (architectural differentiation). In general, cancers that are well-differentiated retain many features of the normal tissue, tend to grow more slowly, and are associated with a better prognosis. Poorly differentiated (anaplastic) tumors have lost these features, appear highly abnormal, and behave more aggressively.\n**Proliferation** refers to the rate of cell division within the tumor. A high proliferative rate is a hallmark of aggressive cancers, as it indicates rapid tumor growth and a greater potential for invasion and metastasis.\n\nThe three components of the Nottingham system measure these concepts:\n\n$1$. **Tubule Formation (or Gland Formation)**: This component assesses the degree of architectural differentiation. It quantifies the percentage of the tumor area that is composed of cells arranged into definite tubular or glandular structures, which mimics the architecture of normal breast ducts and lobules.\n    - A score of $1$ is assigned for tumors with greater than $75\\%$ of the area showing tubule formation. This indicates a well-differentiated tumor that retains a significant degree of its normal tissue organization.\n    - A score of $2$ is assigned for tubule formation between $10\\%$ and $75\\%$.\n    - A score of $3$ is assigned for tumors with less than $10\\%$ tubule formation, where cancer cells grow in solid sheets or as single cells with little to no glandular organization.\n    An increasing score from $1$ to $3$ thus reflects a progressive loss of architectural differentiation, which is a feature of increasingly unfavorable tumor biology.\n\n$2$. **Nuclear Pleomorphism (or Nuclear Atypia)**: This component assesses cytologic differentiation by evaluating the variation in the size and shape of the tumor cell nuclei.\n    - A score of $1$ is assigned when nuclei are small, regular, and uniform in appearance, closely resembling those of normal breast epithelial cells.\n    - A score of $2$ is assigned for nuclei showing moderate variation.\n    - A score of $3$ is assigned for nuclei that exhibit marked variation in size and shape (pleomorphism), often with vesicular chromatin and prominent, eosinophilic nucleoli.\n    An increasing score from $1$ to $3$ reflects increasing nuclear anaplasia. This signifies a greater departure from the normal cellular phenotype and is often associated with significant genetic instability, a key driver of aggressive cancer behavior.\n\n$3$. **Mitotic Count (or Mitotic Rate)**: This component is a direct measure of the tumor's proliferative activity. It involves counting the number of mitotic figures (cells undergoing division) in a specified number of high-power fields (HPFs) in the most mitotically active area of the tumor. The area of an HPF can vary between microscopes, so standardized tables are used to define the score based on the field diameter.\n    - A score of $1$ is given for a low mitotic count.\n    - A score of $2$ is given for an intermediate count.\n    - A score of $3$ is given for a high mitotic count.\n    An increasing score from $1$ to $3$ directly corresponds to a higher rate of cell division. This indicates rapid tumor growth and is strongly correlated with a higher risk of metastasis and a poorer prognosis.\n\nTo determine the final histologic grade, the scores for these three components are summed.\nLet $S_T$ be the score for tubule formation, $S_N$ be the score for nuclear pleomorphism, and $S_M$ be the score for mitotic count. The total score, $S_{Total}$, is given by:\n$$S_{Total} = S_T + S_N + S_M$$\nThe given component scores are:\n- Tubule formation, $S_T = 2$\n- Nuclear pleomorphism, $S_N = 3$\n- Mitotic count, $S_M = 1$\n\nSubstituting these values into the equation:\n$$S_{Total} = 2 + 3 + 1 = 6$$\n\nThe final histologic grade is then determined from the total score based on the following established ranges:\n- **Grade $1$ (Well-differentiated):** Total score of $3$, $4$, or $5$.\n- **Grade $2$ (Moderately differentiated):** Total score of $6$ or $7$.\n- **Grade $3$ (Poorly differentiated):** Total score of $8$ or $9$.\n\nThe calculated total score is $6$. According to the Nottingham grading system, a total score of $6$ falls within the range for Grade $2$.", "answer": "$$\\boxed{2}$$", "id": "4676442"}, {"introduction": "Pathologic assessment of regional lymph nodes has evolved, allowing for the detection of ever-smaller metastatic deposits. Distinguishing between clinically significant metastases and minute tumor deposits is crucial for accurate staging and guiding decisions on adjuvant therapy. This practice exercise [@problem_id:4676450] focuses on the critical American Joint Committee on Cancer (AJCC) thresholds that separate isolated tumor cells (ITCs), micrometastases, and macrometastases, a skill vital for interpreting modern pathology reports and informing multidisciplinary cancer care.", "problem": "A surgeon performs wide local excision and sentinel lymph node biopsy for a patient with invasive ductal carcinoma of the breast. Pathology examines one sentinel lymph node using Hematoxylin and Eosin (H&E) and cytokeratin immunohistochemistry (IHC). A single metastatic deposit is identified, with a measured greatest dimension of $0.15\\,\\mathrm{mm}$ on the examined slide. The pathologist estimates that the deposit comprises fewer than $200$ tumor cells in the largest cross-section, with no additional nodal involvement. Using consensus definitions codified by the American Joint Committee on Cancer (AJCC), choose the option that most accurately compares the threshold criteria for isolated tumor cells versus micrometastases, relates each to the appropriate pathologic nodal staging convention, and classifies the described $0.15\\,\\mathrm{mm}$ deposit.\n\nA. Isolated tumor cells are deposits with greatest dimension $\\leq 0.2\\,\\mathrm{mm}$ and not more than $200$ cells in a single cross-section; micrometastases are deposits $> 0.2\\,\\mathrm{mm}$ and $\\leq 2.0\\,\\mathrm{mm}$ and/or $> 200$ cells; isolated tumor cells correspond to pN0(i+) and micrometastases correspond to pN1mi. The $0.15\\,\\mathrm{mm}$ deposit with fewer than $200$ cells is classified as isolated tumor cells.\n\nB. Micrometastases are deposits with greatest dimension $\\geq 0.1\\,\\mathrm{mm}$ and $< 2.0\\,\\mathrm{mm}$; isolated tumor cells are deposits $< 0.1\\,\\mathrm{mm}$ only. Micrometastases correspond to pN1mi and isolated tumor cells correspond to pN0. The $0.15\\,\\mathrm{mm}$ deposit is a micrometastasis.\n\nC. Isolated tumor cells are deposits with greatest dimension $\\leq 0.2\\,\\mathrm{mm}$ but they do not affect nodal staging and remain pN0 without any suffix; micrometastases are deposits $> 0.2\\,\\mathrm{mm}$ and $\\leq 2.0\\,\\mathrm{mm}$ and correspond to pN1mi. The $0.15\\,\\mathrm{mm}$ deposit is isolated tumor cells and should be staged pN0.\n\nD. Macrometastases are deposits $> 0.2\\,\\mathrm{mm}$; micrometastases are deposits $\\leq 0.2\\,\\mathrm{mm}$. Isolated tumor cells are not recognized in staging. The $0.15\\,\\mathrm{mm}$ deposit is a macrometastasis and corresponds to pN1.", "solution": "The problem statement is evaluated for validity before proceeding to a solution.\n\n### Step 1: Extract Givens\n- **Procedure:** Wide local excision and sentinel lymph node biopsy.\n- **Underlying Diagnosis:** Invasive ductal carcinoma of the breast.\n- **Specimen:** One sentinel lymph node.\n- **Analytic Methods:** Hematoxylin and Eosin (H&E), cytokeratin immunohistochemistry (IHC).\n- **Pathologic Finding:** A single metastatic deposit.\n- **Size of Deposit:** Greatest dimension is $0.15\\,\\mathrm{mm}$.\n- **Cellularity of Deposit:** Estimated to comprise fewer than $200$ tumor cells in the largest cross-section.\n- **Extent of Nodal Disease:** No additional nodal involvement.\n- **Reference Standard:** Consensus definitions codified by the American Joint Committee on Cancer (AJCC).\n- **Question:** Compare the criteria for isolated tumor cells versus micrometastases, relate them to pathologic nodal staging (pN), and classify the given $0.15\\,\\mathrm{mm}$ deposit.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, well-posed, and objective.\n- **Scientific Grounding:** The scenario describes a standard clinical and pathological situation in breast cancer management. The terminology (invasive ductal carcinoma, sentinel lymph node biopsy, H&E, IHC), measurements, and staging conventions (pN, AJCC) are all based on established, well-defined principles of surgical oncology and pathology. The values provided ($0.15\\,\\mathrm{mm}$, $<200$ cells) are realistic.\n- **Well-Posedness:** The problem provides all necessary information to arrive at a definite classification based on the specified reference standard (AJCC). The question is unambiguous and asks for a specific classification and justification.\n- **Objectivity:** The problem is stated using precise, quantitative, and objective language. It refers to an external, codified standard (AJCC), removing subjectivity.\n\n### Step 3: Verdict and Action\nThe problem is **valid**. A solution can be derived by applying the stated principles.\n\n### Derivation of Solution\n\nThe classification of lymph node findings in breast cancer is governed by the AJCC Cancer Staging Manual (8th Edition). The key definitions for pathologic nodal status (pN) are as follows:\n\n1.  **No regional lymph node metastasis** (pN0): No metastasis identified. However, this category has important sub-classifications.\n    -   pN0(i+): **Isolated Tumor Cells (ITCs)** are present. ITCs are defined as single tumor cells or small clusters of cells with a greatest dimension not more than $0.2\\,\\mathrm{mm}$, and typically comprising no more than $200$ cells in a single cross-section of the lymph node. They are often detected by IHC (as in this case) or molecular methods, but may be seen on H&E. ITCs do not change the $N$ category from $N0$, but their presence is noted for prognostic purposes.\n    -   pN0(i-): No ITCs found after IHC staining.\n    -   pN0(mol+): Malignant cells detected only by molecular methods.\n\n2.  **Micrometastasis** (pN1mi): Metastatic deposit(s) in the lymph node(s) where the greatest dimension of the deposit is greater than $0.2\\,\\mathrm{mm}$ and/or it contains more than $200$ cells, but the greatest dimension is not more than $2.0\\,\\mathrm{mm}$. The formal definition can be stated as: (size $> 0.2\\,\\mathrm{mm}$ OR cell count $> 200$) AND (size $\\leq 2.0\\,\\mathrm{mm}$).\n\n3.  **Macrometastasis** (pN1, pN2, pN3): Metastatic deposit(s) in the lymph node(s) with a greatest dimension greater than $2.0\\,\\mathrm{mm}$. The specific stage (pN1, pN2, or pN3) depends on the number and location of the affected lymph nodes.\n\nNow, we apply these definitions to the case provided:\n-   Greatest dimension of the deposit, $d = 0.15\\,\\mathrm{mm}$.\n-   Estimated cell count, $N < 200$.\n\nWe evaluate the criteria for ITCs:\n-   Is the size $\\leq 0.2\\,\\mathrm{mm}$? Yes, $0.15\\,\\mathrm{mm} \\leq 0.2\\,\\mathrm{mm}$.\n-   Is the cell count $\\leq 200$? Yes, \"fewer than $200$\" satisfies the condition of \"not more than $200$\".\n\nSince both criteria for Isolated Tumor Cells are met, the deposit is classified as ITCs. The appropriate pathologic nodal staging is pN0(i+), where the (i+) indicates that ITCs were identified, in this case with the assistance of IHC.\n\n### Evaluation of Options\n\n**A. Isolated tumor cells are deposits with greatest dimension $\\leq 0.2\\,\\mathrm{mm}$ and not more than $200$ cells in a single cross-section; micrometastases are deposits $> 0.2\\,\\mathrm{mm}$ and $\\leq 2.0\\,\\mathrm{mm}$ and/or $> 200$ cells; isolated tumor cells correspond to pN0(i+) and micrometastases correspond to pN1mi. The $0.15\\,\\mathrm{mm}$ deposit with fewer than $200$ cells is classified as isolated tumor cells.**\n-   The definition provided for isolated tumor cells is correct.\n-   The definition for micrometastases is also correct (representing size $> 0.2\\,\\mathrm{mm}$ AND $\\leq 2.0\\,\\mathrm{mm}$, OR cell count $> 200$ within the same size constraints).\n-   The staging correspondence (pN0(i+) for ITCs and pN1mi for micrometastases) is correct.\n-   The classification of the $0.15\\,\\mathrm{mm}$ deposit as isolated tumor cells is correct based on the derivation above.\n-   **Verdict: Correct.**\n\n**B. Micrometastases are deposits with greatest dimension $\\geq 0.1\\,\\mathrm{mm}$ and $< 2.0\\,\\mathrm{mm}$; isolated tumor cells are deposits $< 0.1\\,\\mathrm{mm}$ only. Micrometastases correspond to pN1mi and isolated tumor cells correspond to pN0. The $0.15\\,\\mathrm{mm}$ deposit is a micrometastasis.**\n-   The definition for micrometastases is incorrect. The lower size threshold is $> 0.2\\,\\mathrm{mm}$, not $\\geq 0.1\\,\\mathrm{mm}$.\n-   The definition for isolated tumor cells is incorrect. The upper size threshold is $\\leq 0.2\\,\\mathrm{mm}$, not $< 0.1\\,\\mathrm{mm}$.\n-   The staging for ITCs is given as pN0, which is imprecise. The correct notation is pN0(i+).\n-   The classification of the $0.15\\,\\mathrm{mm}$ deposit as a micrometastasis is incorrect.\n-   **Verdict: Incorrect.**\n\n**C. Isolated tumor cells are deposits with greatest dimension $\\leq 0.2\\,\\mathrm{mm}$ but they do not affect nodal staging and remain pN0 without any suffix; micrometastases are deposits $> 0.2\\,\\mathrm{mm}$ and $\\leq 2.0\\,\\mathrm{mm}$ and correspond to pN1mi. The $0.15\\,\\mathrm{mm}$ deposit is isolated tumor cells and should be staged pN0.**\n-   The statement that ITCs result in a staging of \"pN0 without any suffix\" is incorrect. The AJCC mandates the use of the (i+) suffix to denote their presence, as it carries prognostic information.\n-   While the classification of the deposit is correct, the description of its staging is critically flawed.\n-   **Verdict: Incorrect.**\n\n**D. Macrometastases are deposits $> 0.2\\,\\mathrm{mm}$; micrometastases are deposits $\\leq 0.2\\,\\mathrm{mm}$. Isolated tumor cells are not recognized in staging. The $0.15\\,\\mathrm{mm}$ deposit is a macrometastasis and corresponds to pN1.**\n-   The definition of macrometastases is incorrect. The threshold is $> 2.0\\,\\mathrm{mm}$, not $> 0.2\\,\\mathrm{mm}$.\n-   The definition of micrometastases is incorrect. The description given ($\\leq 0.2\\,\\mathrm{mm}$) actually corresponds to ITCs.\n-   The statement that ITCs are not recognized in staging is incorrect. They are explicitly recognized as pN0(i+).\n-   The classification of the $0.15\\,\\mathrm{mm}$ deposit as a macrometastasis is incorrect.\n-   **Verdict: Incorrect.**", "answer": "$$\\boxed{A}$$", "id": "4676450"}]}